CASI PHARMACEUTICALS, INC. (CASIF) Operating cash flow 2020–2025
CASI PHARMACEUTICALS, INC. (CASIF) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$20.8MFY2025 · since FY2020: -$25.9M → -$20.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$20.8M | +29.0% |
| FY2024 | -$29.2M | -46.4% |
| FY2023 | -$20.0M | +5.3% |
| FY2022 | -$21.1M | +21.4% |
| FY2021 | -$26.8M | -3.7% |
| FY2020 | -$25.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CASIF financial trends
CASIF RevenueCASIF Net incomeCASIF Net marginCASIF Gross profitCASIF Gross marginCASIF Operating incomeCASIF Operating marginCASIF Free cash flowCASIF Capital expendituresCASIF Return on equityCASIF Stock buybacksCASIF Dividends paidCASIF Total assetsCASIF Total liabilitiesCASIF Shareholders’ equityCASIF overview →